T3	Subject 35 56	parkinsonian patients
T4	Treatment 62 71	levo-dopa
T6	Effect 80 100	diphasic dyskinesias
T8	Drug 62 71	levo-dopa
T9	Treat-Disorder 35 47	parkinsonian
T11	Treat-Disorder 62 100	levo-dopa-induced diphasic dyskinesias
T12	Effect 166 184	abnormal movements
T13	Treatment 115 139	subcutaneous apomorphine
T14	Drug 115 139	subcutaneous apomorphine
